AU5619100A - Intracellular signaling molecules - Google Patents
Intracellular signaling moleculesInfo
- Publication number
- AU5619100A AU5619100A AU56191/00A AU5619100A AU5619100A AU 5619100 A AU5619100 A AU 5619100A AU 56191/00 A AU56191/00 A AU 56191/00A AU 5619100 A AU5619100 A AU 5619100A AU 5619100 A AU5619100 A AU 5619100A
- Authority
- AU
- Australia
- Prior art keywords
- intracellular signaling
- signaling molecules
- molecules
- intracellular
- signaling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13956699P | 1999-06-16 | 1999-06-16 | |
US60139566 | 1999-06-16 | ||
US14964099P | 1999-08-17 | 1999-08-17 | |
US60149640 | 1999-08-17 | ||
US16441799P | 1999-11-09 | 1999-11-09 | |
US60164417 | 1999-11-09 | ||
PCT/US2000/016636 WO2000077040A2 (en) | 1999-06-16 | 2000-06-16 | Human intracellular signaling molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5619100A true AU5619100A (en) | 2001-01-02 |
Family
ID=27385364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU56191/00A Abandoned AU5619100A (en) | 1999-06-16 | 2000-06-16 | Intracellular signaling molecules |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1203081A2 (en) |
JP (1) | JP2003530071A (en) |
AU (1) | AU5619100A (en) |
CA (1) | CA2374909A1 (en) |
WO (1) | WO2000077040A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3593482B2 (en) * | 1999-11-24 | 2004-11-24 | 独立行政法人 科学技術振興機構 | Human nucleoprotein having WW domain and cDNA encoding the same |
WO2001042294A2 (en) * | 1999-12-13 | 2001-06-14 | Arbor Vita Corporation | Clasp-4 transmembrane protein |
EP1268816A2 (en) * | 2000-03-30 | 2003-01-02 | MERCK PATENT GmbH | Calcium-binding regulatory subunit |
WO2003014298A2 (en) * | 2001-08-03 | 2003-02-20 | Origene Technologies, Inc. | Full-length prostate selective polynucleotides and polypeptides |
DE10222845A1 (en) * | 2002-05-23 | 2003-12-04 | Dresden Arzneimittel | Cloning, expression and characterization of the overall sequence of phosphodiesterase 8B |
AU2003279323A1 (en) * | 2002-11-08 | 2004-06-07 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
WO2004045519A2 (en) * | 2002-11-14 | 2004-06-03 | Kirk Sperber | Induction of apoptosis by hiv-1 infected monocytic cells |
CA2631397A1 (en) | 2005-12-01 | 2007-06-07 | Leszek Kotula | Peptide inhibitors of abl kinases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69233214T2 (en) * | 1991-04-19 | 2004-07-01 | The Board Of Regents Of The University Of Washington, Seattle | DNA ENCODING MAMMAL PHOSPHODIESTERASES |
US5969101A (en) * | 1995-10-27 | 1999-10-19 | Duke University | ABL-interactor protein |
WO1997044347A1 (en) * | 1996-05-21 | 1997-11-27 | Smithkline Beecham Corporation | Human cis protein |
-
2000
- 2000-06-16 WO PCT/US2000/016636 patent/WO2000077040A2/en not_active Application Discontinuation
- 2000-06-16 AU AU56191/00A patent/AU5619100A/en not_active Abandoned
- 2000-06-16 EP EP00941487A patent/EP1203081A2/en not_active Withdrawn
- 2000-06-16 CA CA002374909A patent/CA2374909A1/en not_active Abandoned
- 2000-06-16 JP JP2001503896A patent/JP2003530071A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2000077040A2 (en) | 2000-12-21 |
CA2374909A1 (en) | 2000-12-21 |
WO2000077040A3 (en) | 2001-04-26 |
JP2003530071A (en) | 2003-10-14 |
EP1203081A2 (en) | 2002-05-08 |
WO2000077040A9 (en) | 2002-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5151100A (en) | Extracellular signaling molecules | |
AU1173201A (en) | Skin-gripper | |
AU3092999A (en) | Digital-timeshare-exchange | |
AU2001271434A1 (en) | Novel skateboard-bicycle combination | |
AUPQ339899A0 (en) | Novel molecules | |
AU2678800A (en) | Modified calycins | |
AU4581300A (en) | Synthetic signalling molecules | |
AU7030200A (en) | Edgings | |
AU5995400A (en) | Signalling system | |
AU4115400A (en) | Short-circuiter | |
AU4309700A (en) | Spectacles | |
AU2002212445A1 (en) | Signalling means | |
AU2002359242A1 (en) | Intracellular signaling molecules | |
AU2023701A (en) | Sketcher | |
AU2804600A (en) | Arylaminoalkylamides | |
AU5619100A (en) | Intracellular signaling molecules | |
AU2002365195A1 (en) | Intracellular signaling molecules | |
AU4974700A (en) | Fluoroalkenyl nortropanes | |
AU2699800A (en) | Organoceramics | |
AU2002305861A1 (en) | Intracellular signaling molecules | |
AU2002350174A1 (en) | Intracellular signaling molecules | |
AU4561600A (en) | Benzofuranylaminoalcohols | |
AU2002216625A1 (en) | Intracellular signaling molecules | |
AU2001275401A1 (en) | Intracellular signaling proteins | |
AU1901801A (en) | Glucofuranoses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |